Clinical Trials/DRKS00028846

DRKS00028846

Not yet recruiting

Not Applicable

Effect of direct-acting antiviral (DAA) drugs on HCV epidemiology among patients in public hospitals in southern Hessen, Germany.

Johann Wolfgang Goethe-Universität Frankfurt0 sites10,000 target enrollmentJuly 20, 2022

ConditionsPatients' blood is tested for hepatitis C virus (HCV) antibodies. If the result is positive, the next step is to check for HCV RNA to detect an active infection.

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Patients' blood is tested for hepatitis C virus (HCV) antibodies. If the result is positive, the next step is to check for HCV RNA to detect an active infection.
Sponsor: Johann Wolfgang Goethe-Universität Frankfurt
Enrollment: 10000
Status: Not yet recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

July 20, 2022

End Date

TBD

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Johann Wolfgang Goethe-Universität Frankfurt

Eligibility Criteria

Inclusion Criteria

•Consenting patients over the age of 18 presenting for elective surgery or emergency care to a public hospital in southern Hessen, Germany

Exclusion Criteria

•Patients under 18 years of age, patients with a known HCV infection

Outcomes

Primary Outcomes

Not specified

Similar Trials

Improvement of Mood and Cognition in patients with chronic hepatitis C infection after specific treatment for HCV.

CTRI/2019/04/018385Postgraduate Institute of Medical Education and Research

Resarch of the effect of antiviral drugs on the suppression of COVID-19 persistent symptomsCOVID-19

JPRN-UMIN000048380agasaki University382

Effect of antiviral therapy in patients with acute respiratory distress syndrome after CAP (community acquired pneumonia) and H1N1 infection on health-related quality of life (HRQoL) and cognitive performanceacute respiratory distress syndromeJ80Adult respiratory distress syndrome

DRKS00011913Charité Universitätsmedizin Berlin Klinik für Anästhesiologie m. S. Intensivmedizin Campus Benjamin Franklin42

Comparison of DAAs(Direct Acting Antivirals) and interferon-based triple therapy for hepatitis C after treatment of hepatocelluler carcinoma.Hepatitis C after treatment for hepatocelluler carcinoma.

JPRN-UMIN000014971Musashino Red Cross Hospital100

Enrolling By Invitation

Effectiveness and safety of direct acting antivirals for the management of patients with chronic hepatitis C virus in Thailand : A real-life multicenter study.1.End of treatment response (ETR) is the rate of treatment response. At the temple at the time of study discontinuance Which is divided into biochemical responses (with liver enzymes&#44ALT) and virologDAA.Chornic hepatitis C.

TCTR20200313005one200